Outcome of Corneal transplantation rejection
- PMID: 11333319
- DOI: 10.1097/00003226-200105000-00002
Outcome of Corneal transplantation rejection
Abstract
Purpose: To identify predictive factors for reversibility of corneal graft rejection.
Methods: The study design was a prospective cohort study. Among 440 consecutive penetrating keratoplasties performed at our institution, 79 grafts from 79 patients who developed signs of transplant rejection were included. Donor, recipient, surgical, and rejection variables were studied, at both univariate and multivariate levels.
Results: The rate of reversibility was 51% (40/79). The average postoperative time of rejection was 10.5 +/- 9.3 months, and the average time of visual acuity recovery in patients with reversible rejection was 2.4 +/- 2.3 months. In logistic regression, only two variables significantly influenced the rate of reversibility. The preoperative diagnosis (p = 0.04) influenced the rate of rejection reversibility; patients with bullous keratopathy or regraft were more likely to experience irreversible rejection than patients with keratoconus or Fuchs' dystrophy. The average graft thickness at the time of rejection diagnosis was 774 +/- 129 microm in patients with irreversible rejection and 681 +/- 118 microm in patients with reversible rejection (p = 0.001).
Conclusion: Rejection was reversible in half of the cases. Rejection was more likely to be irreversible in patients with marked increase in graft thickness and in patients transplanted for bullous keratopathy or graft failure. Donor variables did not influence rejection reversibility.
Similar articles
-
Visual outcome in corneal grafts: a preliminary analysis of the Swedish Corneal Transplant Register.Br J Ophthalmol. 2002 Feb;86(2):174-80. doi: 10.1136/bjo.86.2.174. Br J Ophthalmol. 2002. PMID: 11815343 Free PMC article.
-
Long-term graft survival after penetrating keratoplasty.Ophthalmology. 2003 Jul;110(7):1396-402. doi: 10.1016/S0161-6420(03)00463-9. Ophthalmology. 2003. PMID: 12867398
-
A comparison of lamellar and penetrating keratoplasty outcomes: a registry study.Ophthalmology. 2014 May;121(5):979-87. doi: 10.1016/j.ophtha.2013.12.017. Epub 2014 Feb 1. Ophthalmology. 2014. PMID: 24491643
-
Indications for and outcomes of penetrating keratoplasty performed by resident surgeons.Am J Ophthalmol. 2003 Jul;136(1):68-75. doi: 10.1016/s0002-9394(02)02295-x. Am J Ophthalmol. 2003. PMID: 12834672
-
The Australian Corneal Graft Registry. 1990 to 1992 report.Aust N Z J Ophthalmol. 1993 May;21(2 Suppl):1-48. Aust N Z J Ophthalmol. 1993. PMID: 8333942 Review.
Cited by
-
Strategies for local gene therapy of corneal allograft rejection.Middle East Afr J Ophthalmol. 2013 Jan-Mar;20(1):11-25. doi: 10.4103/0974-9233.106382. Middle East Afr J Ophthalmol. 2013. PMID: 23580848 Free PMC article. Review.
-
Terahertz sensing in corneal tissues.J Biomed Opt. 2011 May;16(5):057003. doi: 10.1117/1.3575168. J Biomed Opt. 2011. PMID: 21639581 Free PMC article.
-
Impact of pandemic COVID-19 lockdown on penetrating keratoplasty patients.Indian J Ophthalmol. 2023 Jan;71(1):95-100. doi: 10.4103/ijo.IJO_1190_22. Indian J Ophthalmol. 2023. PMID: 36588216 Free PMC article.
-
Role of Immune Cell Diversity and Heterogeneity in Corneal Graft Survival: A Systematic Review and Meta-Analysis.J Clin Med. 2021 Oct 12;10(20):4667. doi: 10.3390/jcm10204667. J Clin Med. 2021. PMID: 34682792 Free PMC article. Review.
-
Establishment of a murine model of chronic corneal allograft dysfunction.Graefes Arch Clin Exp Ophthalmol. 2010 Oct;248(10):1437-45. doi: 10.1007/s00417-010-1403-0. Epub 2010 May 16. Graefes Arch Clin Exp Ophthalmol. 2010. PMID: 20473766
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources